Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
ZHONGZHIPHARM: INTERIM REPORT 2024
Sep 16 05:05 ET
ZHONGZHIPHARM: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024
Aug 23 07:56 ET
ZHONGZHIPHARM: NOTIFICATION OF BOARD MEETING
Aug 13 04:30 ET
ZHONGZHIPHARM: PROFIT WARNING
Jul 12 04:41 ET
Read more
No Data